MORGAN STANLEY - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,179,031
-74.5%
222,040
-54.3%
0.00%
Q2 2023$4,631,368
+24.7%
485,978
+43.9%
0.00%
Q1 2023$3,714,194
+26.7%
337,654
+70.5%
0.00%
Q4 2022$2,931,347
+22.8%
198,064
+58.5%
0.00%
Q3 2022$2,387,000
+3.6%
124,926
+15.5%
0.00%
Q2 2022$2,304,000
+22.7%
108,169
+11.0%
0.00%
Q1 2022$1,878,000
+70.9%
97,452
+83.8%
0.00%
Q4 2021$1,099,000
-68.0%
53,019
-63.1%
0.00%
Q3 2021$3,434,000
-44.5%
143,746
-36.6%
0.00%
-100.0%
Q2 2021$6,185,000
+70.1%
226,673
+80.3%
0.00%0.0%
Q1 2021$3,636,000
-15.0%
125,712
-17.3%
0.00%0.0%
Q4 2020$4,277,000
+5053.0%
152,010
+5323.1%
0.00%
Q3 2020$83,000
-23.1%
2,803
-21.6%
0.00%
Q2 2020$108,000
+151.2%
3,573
+148.6%
0.00%
Q1 2020$43,0001,4370.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$165,956,00012.78%
Bain Capital Life Sciences Investors, LLC 3,000,000$57,330,0006.84%
Pivotal bioVenture Partners Investment Advisor LLC 569,041$10,874,0003.97%
Logos Global Management LP 1,525,000$29,143,0003.58%
1492 Capital Management LLC 178,320$3,408,0002.45%
Cormorant Asset Management, LP 1,000,000$19,110,0001.34%
MPM BioImpact LLC 257,185$4,915,0001.16%
Orbimed Advisors 2,800,000$53,508,0000.99%
SECTORAL ASSET MANAGEMENT INC 220,985$4,223,0000.83%
Rubric Capital Management LP 472,047$9,021,0000.45%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders